CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Millions		Mar. 31, 2023	Sep. 30, 2022
Current assets
Cash and cash equivalents		$ 399	$ 646
Accounts receivable - Note H	[1]	395	402
Inventories - Note F		730	629
Other assets		107	91
Total current assets		1,631	1,768
Property, plant and equipment
Cost		3,164	3,050
Accumulated depreciation		1,813	1,712
Net property, plant and equipment		1,351	1,338
Goodwill - Note G		1,385	1,312
Intangibles - Note G		940	963
Operating lease assets, net - Note I		124	107
Restricted investments - Note E		349	313
Asbestos insurance receivable - Note L	[2]	133	138
Deferred income taxes		20	20
Other assets		250	254
Total noncurrent assets		4,552	4,445
Total assets		6,183	6,213
Current liabilities
Trade and other payables		246	265
Accrued expenses and other liabilities		206	269
Current operating lease obligations - Note I		20	19
Total current liabilities		472	553
Noncurrent liabilities
Long-term debt - Note H		1,328	1,270
Asbestos litigation reserve - Note L		443	472
Deferred income taxes		175	176
Employee benefit obligations - Note K		110	103
Operating lease obligations - Note I		108	94
Other liabilities		280	325
Total noncurrent liabilities		2,444	2,440
Commitments and contingencies - Note L
Stockholders' equity - Note N		3,267	3,220
Total liabilities and stockholders' equity		$ 6,183	$ 6,213

[1] Accounts receivable includes an allowance for credit losses of $4 million at both March 31, 2023 and September 30, 2022.

[2] Asbestos insurance receivable includes an allowance for credit losses of $3 million at both March 31, 2023 and September 30, 2022.